Search
Showing results for "Childhood interstitial lung disease "
We sought to investigate the long-term unemployment rate and baseline predictors of employment status at follow-up in a large ultra-high risk cohort.
How different somatosensory modalities develop across childhood into adolescence to use as a point of reference for children at risk of somatosensory
Engagement with preschool programs in Australia may present a plausible, equitable, and modifiable approach to improving children's developmental outcomes
A lovable blue creature by the name of Bobbie has won the hearts and minds of Western Australians.
Bushfires can have a considerable impact on our physical and mental health, with some symptoms lasting long after the blaze is extinguished. And our children are amongst the most vulnerable.
Detailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden over time and across age groups, sexes, and locations. The availability of disease burden estimates can promote evidence-based interventions that enable public health researchers, policy makers, and other professionals to implement strategies that can mitigate diseases.
To improve diabetes management in primary health care for the Aboriginal and Torres Strait Islander peoples population, training programs that are culturally and contextually relevant to the local context are required. Using a scoping review methodology, the aim of this review was to describe the characteristics of chronic disease management training programs for Aboriginal Health Workers and Practitioners, their effectiveness on knowledge and skills, and client-related outcomes, and the enablers, barriers to delivery and participation.
Thanks to a $1 million funding grant, Dr Asha Bowen from The Kids Research Institute Australia is on track to change Aboriginal children's skin infection statistics.
The Australasian guidelines recommend use of the CHA2 DS2 -VA schema to stratify ischaemic stroke risk in patients with non-valvular atrial fibrillation (N-VAF) and determine risk thresholds for recommending oral anticoagulant (OAC) therapy. However, the CHA2 DS2 -VA score has not been validated in a representative Australian population cohort with N-VAF, including in Aboriginal people who are known to have a higher age-adjusted stroke risk than other Australians.
The excess stroke incidence in Aboriginal South Australians appears substantial, especially in those aged <55 years